Foundations Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$220K	Hold	3,901	–	–	﹤0.01%	1070
2025 Q4	$232K	Hold	3,901	–	–	﹤0.01%	1000
2025 Q3	$211K	Sell	3,901 -2	-0.1%	-$114	﹤0.01%	980
2025 Q2	$215K	Sell	3,903 -66	-2%	-$3.89K	﹤0.01%	866
2025 Q1	$281K	Sell	3,969 -97	-2%	-$6.53K	0.01%	728
2024 Q4	$267K	Buy	4,066 +161	+4%	+$10.8K	0.01%	689
2024 Q3	$274K	Buy	3,905 +4	+0.1%	+$334	0.01%	663
2024 Q2	$321K	Hold	3,901	–	–	0.01%	592
2024 Q1	$341K	Hold	3,901	–	–	0.01%	550
2023 Q4	$346K	Hold	3,901	–	–	0.01%	518
2023 Q3	$345K	Sell	3,901 -20	-0.5%	-$1.78K	0.01%	480
2023 Q2	$340K	Hold	3,921	–	–	0.01%	446
2023 Q1	$381K	Sell	3,921 -50	-1%	-$5.18K	0.01%	362
2022 Q4	$411K	Sell	3,971 -898	-18%	-$84.3K	0.02%	305
2022 Q3	$413K	Buy	+4,869	New	+$434K	0.02%	281